4.6 Article

Major Histocompatibility Complex Class II Deficiency in Kuwait: Clinical Manifestations, Immunological Findings and Molecular Profile

Journal

JOURNAL OF CLINICAL IMMUNOLOGY
Volume 33, Issue 3, Pages 513-519

Publisher

SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10875-012-9831-8

Keywords

MHC class II deficiency; RFXANK gene; molecular diagnosis; consanguinity; Kuwait

Categories

Funding

  1. Swiss National Science Foundation [PASMP3-127678]
  2. Kuwait Foundation for Advancement of Sciences [2010-1302-05]
  3. Swiss National Science Foundation (SNF) [PASMP3-127678] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

Major Histocompatibility Complex (MHC) class II deficiency is a combined primary immunodeficiency disease that leads to overwhelming and recurrent infections. It was found to account for 19 % of combined immune deficiency cases in the National Primary Immunodeficiency Disorders Registry in Kuwait, a country with high prevalence of consanguinity. We present the clinical, immunologic and molecular features of 11 Kuwaiti patients who presented with MHC class II deficiency between 2004 and 2011.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available